Voice your opinion on congressional bill S898-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Fair Accountability and Innovative Research Drug Pricing Act of 2021

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

HR19-117, HR9655-117,

Senate Actions

IntroReferral
Mar. 23 2021	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
Mar. 23 2021	Introduced in Senate

Senate bill S898-117

Fair Accountability and Innovative Research Drug Pricing Act of 2021

Senate bill S898-117

Fair Accountability and Innovative Research Drug Pricing Act of 2021

Promote the cause!

Or use this QR code